← Back to Search

Behavioural Intervention

School Clinician Training Program for ADHD ((CLS-A-FUERTE) Trial)

N/A
Waitlist Available
Led By Lauren Haack, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must not have
All Participants: Anyone who does not speak and read Spanish will be excluded, given that all informed consent, measurement, and activity procedures will be conducted in Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and post treatment (8 weeks) and follow-up (3 months)
Awards & highlights
No Placebo-Only Group

Summary

This trial aimed to create and evaluate a program to help school clinicians in Mexico treat children with ADHD and ODD. The program, called Collaborative Life Skills (CLS), was tested in different versions,

Who is the study for?
This trial is for students with ADHD/ODD in Mexico. School clinicians will be trained to implement the CLS-A-FUERTE program, which includes digital enhancements and adaptations based on school resources. Students must attend participating schools where this new approach will be compared to usual school services.
What is being tested?
The effectiveness of the CLS-A-FUERTE training and intervention program for ADHD/ODD is being tested across Mexican schools. The study aims to see if students improve more with this program than with standard care, and how well teachers and families can engage with it.
What are the potential side effects?
Since this trial involves educational and behavioral interventions rather than medications, traditional side effects are not expected. However, there may be indirect effects such as increased stress or resistance to change from participants adapting to new techniques.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I speak and read Spanish fluently.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and post treatment (8 weeks) and follow-up (3 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and post treatment (8 weeks) and follow-up (3 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Child Symptom Inventory-4 (CSI-4) Parent Checklist ADHD Combined type Symptom Severity Score
Change in Child Symptom Inventory-4 (CSI-4) Teacher Checklist ADHD Combined type Symptom Severity Score
Secondary study objectives
Change Impairment Rating Scale (IRS) Parent Questionnaire Overall Severity Score
Change Impairment Rating Scale (IRS) Teacher Questionnaire Overall Severity Score
Change in Child Symptom Inventory-4 (CSI-4) Parent Checklist (Oppositional Defiant Disorder) ODD Symptom Severity Score
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CLS-A-FUERTEExperimental Treatment1 Intervention
Receiving the CLS-A-FUERTE program immediately
Group II: School Services as Usual (SA)Active Control1 Intervention
Receiving School Services as Usual while waiting to receive the CLS-A-FUERTE program in the subsequent schoolyear

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,586 Previous Clinical Trials
14,899,046 Total Patients Enrolled
8 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
850 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Fogarty International Center of the National Institute of HealthNIH
151 Previous Clinical Trials
170,527 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
31 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Lauren Haack, PhDPrincipal InvestigatorUniversity of California, San Francisco
~667 spots leftby Jun 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top